Executive Summary

On 21 July 2026, Martina Hirayama, State Secretary for Education, Research and Innovation, participated in the informal meeting of EU research ministers in Dublin. The meeting under the Irish Council Presidency focused on two priorities: building a European knowledge and innovation market and increasing Europe's innovation performance. Hirayama emphasized the importance of open, excellence-based research systems and cross-border collaboration. In parallel, she conducted bilateral talks with representatives from Germany, Austria, the United Kingdom, and the European Commission.

Persons

  • Martina Hirayama (State Secretary for Education, Research and Innovation, Switzerland)
  • Dorothee Bär (Federal Minister for Research, Technology and Space Travel, Germany)
  • Eva-Maria Holzleitner (Federal Minister for Women, Science and Research, Austria)

Topics

  • European knowledge market
  • Research and innovation policy
  • Research competitiveness
  • Cross-border collaboration
  • Researcher mobility

Clarus Lead

Switzerland positions itself strategically as an actor in the European research space, while EU states seek to consolidate their fragmented innovation landscape. Hirayama's focus on open and interoperable infrastructures signals that Switzerland wants to advance collaboration with the EU independent of formal bilateral agreements—a signal for the ongoing Bilateral III package. The emphasis on talent promotion and science-industry cooperation addresses Europe's central weakness: the commercialization of research. Simultaneously, Switzerland uses the meeting to demonstrate its technological strength (example: the language model Apertus) as proof of the potential of open, decentralized research ecosystems.

Detailed Summary

The Dublin meeting addressed two interlocking challenges: First, the creation of a unified European knowledge market that makes researchers mobile and facilitates cross-border collaboration. Hirayama argued that this can only be achieved through effective framework conditions, talent promotion, and close integration between science, industry, and public actors. Second, the conversion of scientific excellence into competitiveness—a core problem for Europe, which lags behind the USA and Asia in the commercialization of research results.

Hirayama's reference to the language model Apertus (developed by ETH Zurich, EPFL, and CSCS) illustrates a concrete model: excellent research + effective infrastructure + international cooperation = strategic technology. This underscores that Switzerland does not innovate in isolation, but functions as a hub in a decentralized European system. The bilateral talks with Germany, Austria, the United Kingdom, and the European Commission suggest that Switzerland wants to consolidate its role in the European research space independent of institutional treaties—a strategy relevant to negotiations on Bilateral III.

Key Statements

  • Switzerland emphasizes open, excellence-based research systems as a counterpoint to national protectionist tendencies.
  • Cross-border collaboration is indispensable for strategic technology areas—an argument for deeper EU integration.
  • The commercialization of research remains Europe's Achilles heel; Switzerland positions itself as a model for science-industry integration.
  • Switzerland uses multilateral and bilateral channels in parallel to secure its research strength.

Critical Questions

  1. Evidence: How is the effectiveness of the European knowledge market measured? What indicators for researcher mobility and cross-border collaboration were discussed?

  2. Source Validity: Is Hirayama's statement on "diversity of European innovation ecosystems as strength" based on empirical data or is it a normative position?

  3. Conflicts of Interest: To what extent does Switzerland (with its top universities and research infrastructures) benefit disproportionately from an open European market, and could this disadvantage other countries?

  4. Causality: Is it assumed that better framework conditions automatically lead to more innovation, or are there other factors (capital availability, regulation, market size)?

  5. Feasibility: How concrete are the plans for "interoperable research infrastructures"? What technical and legal hurdles exist?

  6. Strategic Dimension: Is Switzerland deliberately using this conference to strengthen its position in the Bilateral III negotiations without making this explicit?

  7. Representativeness: Which countries or research areas were underrepresented or absent from the debate?

Sources

Primary Source: Package Switzerland-EU: Switzerland Presents Research Excellence at EU Ministers Conference – news.admin.ch, 21.07.2026

Verification status: ✓ 21.07.2026

This text was created with the support of an AI model. Editorial Responsibility: clarus.news | Fact-Check: 21.07.2026